Related Experiment Videos
[Effectiveness of piperacillin in childhood infections]
Abstract:
Piperacillin is a semisynthetic penicillin with a broad-spectrum: in particular it is active against Gram positive, Gram negative, aerobic and anaerobic bacteria often resistant to other antibiotics of the same group. We report a trial carried out on 38 children with severe and moderate infections treated with piperacillin. We have considered ESR, all leucocytes count and body temperature. No severe side effects have been reported. Piperacillin must be used as a first choice in pediatric age, mostly in case of mixed bacterial infections and in immunocompromised patients.
Insights
Piperacillin is a broad-spectrum antibiotic effective against resistant bacteria. A study found it safe and effective for treating severe infections in children, making it a top choice for pediatric mixed bacterial infections.
Area of Science:
- Pharmacology
- Microbiology
- Pediatrics
Context:
- Piperacillin is a broad-spectrum semisynthetic penicillin antibiotic.
- It exhibits activity against Gram-positive, Gram-negative, aerobic, and anaerobic bacteria.
- Notably, it is effective against strains resistant to other penicillins.
Purpose:
- To evaluate the efficacy and safety of piperacillin in treating severe and moderate infections in pediatric patients.
- To assess clinical and laboratory parameters including ESR, leucocyte count, and body temperature.
Summary:
- A clinical trial involved 38 children with severe and moderate infections treated with piperacillin.
- Observed outcomes included Erythrocyte Sedimentation Rate (ESR), total leucocyte count, and body temperature.
- No severe adverse effects were reported during the trial.
Impact:
- Piperacillin demonstrates significant efficacy and a favorable safety profile in pediatric infections.
- The findings support piperacillin as a first-line treatment option for children.
- It is particularly recommended for mixed bacterial infections and immunocompromised pediatric patients.